Models of action selection postulate the critical involvement of the subthalamic nucleus (STN), especially in reactive inhibition processes when inappropriate responses to a sudden stimulus must be overridden. The STN could also play a key role during proactive inhibition, when subjects prepare to potentially suppress their actions. Here, we hypothesized that STN responses to reactive and proactive inhibitory control might be driven by different underlying mechanisms with specific temporal profiles. Direct neural recordings in twelve Parkinson's disease patients during a modified stop signal task (SST) revealed a decrease of beta band activity (βA, 13-35 Hz) in the STN during reactive inhibition of smaller amplitude and shorter duration than during motor execution. Crucially, the onset latency of this relative increase of βA took place before the stop signal reaction time. It could thus be thought of as a "stop" signal inhibiting thalamo-cortical activity that would have supported motor execution. Finally, results also revealed a higher level of βA in the STN during proactive inhibition, which correlated with patient's inhibitory performances. We propose that βA in the STN would here participate in the implementation of a "hold your horse" signal to delay motor responses, thus prioritizing accuracy as compared to speed. In brief, our results provide strong electrophysiological support for the hypothesized role of the STN during executive control underlying proactive and reactive response suppression.
Introduction
The ability to inhibit unwanted actions is a hallmark of executive control. Current models of action suppression distinguish between reactive stopping, when subjects are required to inhibit an action in response to infrequent stimuli (Aron and Poldrack, 2006; Li et al., 2008) and proactive stopping, when subjects stand ready to inhibit forthcoming actions when necessary (Ballanger et al., 2009; Chikazoe et al., 2009) . Functional magnetic resonance imaging (fMRI) studies have identified a prefrontal-subcortical network supporting both types of executive control processes, and established within this network the important involvement of the subthalamic nucleus (STN, Aron and Poldrack, 2006; Ballanger et al., 2009; Chikazoe et al., 2009) .
Although proactive and reactive inhibitory processes are related, different predictions about their respective time course of STN activity can be made. One model postulates that during the stop signal task (SST), the STN participates in reactive stopping by relaying a "STOP" signal to quickly inhibit thalamo-cortical activation through the direct glutamatergic excitation of the globus pallidus pars interna, which in turn sends GABAergic inhibitory signals to the thalamus (Aron and Poldrack, 2006) . In particular, this model predicts a phasic increase of STN activity triggered by a STOP cue at a latency that should precede the stop signal reaction time (SSRT, which provides an estimation of the amount of time necessary to process the stop signal and to inhibit the prepared response, Logan et al., 1984; Schall and Godlove, 2012; Verbruggen and Logan, 2008) . Another model predicts that the STN is also involved during proactive inhibitory control by mediating a "hold your horse" signal to dynamically delay response execution, when subjects tend to favor accuracy over speed (Aron, 2011; Ballanger et al., 2009; Frank et al., 2007; van Maanen et al., 2011) . Thus, the proactive inhibition hypothesis predicts a tonic change of STN activity, for example when subjects prepare to eventually stop their response in a near future. This type of behavior is typical during the stop signal task because subjects slightly slow-down their responses (compared to their maximal response speed) due to the unpredictability of stop cues. This type of proactive inhibitory control may reflect a modulation of a decision threshold in the STN (Aron, 2011; Ballanger et al., 2009;  Contents lists available at ScienceDirect NeuroImage j o u r n a l h o m e p a g e : w w w . e l s e v i e r . c o m / l o c a t e / y n i m g Chikazoe et al., 2009; Frank et al., 2007; Jahfari et al., 2010; van Maanen et al., 2011) .
This study aimed at clarifying the temporal dynamics of the STN during proactive and reactive inhibition using local field potential (LFP) recordings of the STN performed in patients suffering from Parkinson's disease (PD). We tested the abovementioned model predictions using a version of the stop signal task (SST) modified to dissociate reactive inhibition and proactive inhibition, while controlling for a potential attentional confound (Chikazoe et al., 2009; Logan et al., 1984; Sharp et al., 2010) . We determined the amount of time required to dissociate using LFPs the trials involving reactive stopping from motor execution trials. We also quantified STN involvement during proactive inhibitory control by contrasting trials involving a "preparation to stop" component and trials during which this component was absent. We focused the analysis of LFP signals on beta band activity (βA, ) because (i) this neural marker is a signature of the sensorimotor STN (Chen et al., 2006; Miyagi et al., 2009 ), (ii) βA is correlated to the akineto-rigidity syndrome (Zaidel et al., 2010) , (iii) βA supports inhibitory processes (Alegre et al., 2012; Kuhn et al., 2004; Ray et al., 2011; Swann et al., 2009 ) and (iv) βA is correlated with irregular bursting activity in PD (Kuhn et al., 2005) .
Materials and methods

Participants
Data were obtained from 12 PD patients (5 males and 7 females, mean ± SEM age: 59 ± 2 y.o.), selected for their capacity and readiness of collaborating in a demanding cognitive task. They had no psychiatric comorbidity, and were undergoing bilateral STN implantation of deep brain stimulation (DBS) electrodes using standard surgical procedure and inclusion criteria for PD (Benabid et al., 2009) . Table 1 summarizes the clinical characteristics of the patients. They had been suffering from idiopathic PD for 12 ± 1 years. They responded well to Levodopa (Unified Parkinson Disease Rating Scale, UPDRS ON Levodopa: 12.3 ± 2; OFF Levodopa: 39.3 ± 1) and had disabling motor fluctuations and/or Levodopa-induced dyskinesia refractory to the adjustment of antiparkinsonian medication. They presented no relevant deterioration in overall cognitive evaluation (Table 1 , average Mattis Dementia Score was 139.8 ± 1, range 130-144, on a scale from 0 to 144, with higher scores indicating preserved cognition, Pillon et al., 2000) and only relatively mild dysexecutive syndrome (frontal score: 41.2 ± 2, on a scale from 0 to 50, with a higher score indicating preserved executive functions, Pillon et al., 1986) . Subthalamic signals were recorded in patients on their usual therapeutic medication (Table 1 ). All patients gave their written informed consent to participate in this study that was approved by our local ethical committee (Comité de Protection des Personnes Sud-Est I, protocol number: 2011-A00083-38).
Electrode implantation and local field potential recordings
Data were obtained at patient's bedside in the Neurosurgery Department of Grenoble University Hospital during the three days following the bilateral implantation of DBS electrodes (macro-electrode 3389, Medtronic, Minneapolis, US) in the STN using a standard clinical procedure (Benabid et al., 2005 (Benabid et al., , 2009 Chabardes et al., 2012; Piallat et al., 2011) . Experiments were performed before definitive connection of electrodes to the stimulating device that was performed in the following days. LFP signals were recorded with lead extensions connected to an EEG acquisition system (Micromed SD MRI, bandwidth 0.15-600 Hz, sampling rate 2048 Hz). Each DBS electrode consisted of 4 contacts with a length of 1.5 mm, separated by 0.5 mm. Reference and ground were chosen at the tip of the left electrode. Signal processing was performed using a longitudinal bipolar montage between the 3 adjacent pairs of contacts per electrode to maximize the sensitivity to local sources of LFP.
Experimental procedure
Patients completed on average 770 ± 20 trials of a modified version of the SST, which was composed of four types of trials (GO, STOP, GF, GC, see below) presented in a pseudo-randomized order (Fig. 1A) . The majority (52.6%) of trials were GO trials, which consisted of an imperative GO cue (a white circle subtending 1°of visual angle) that prompted patients to press a button with the right index as fast as they could. During STOP trials (15.8% of trials), patients were asked to inhibit their prepared movement in response to a STOP cue (a white cross subtending 1°of visual angle) that unpredictably followed the GO cue after a variable delay (the stop signal delay, SSD). During GF trials (GO-Fast, GF; 15.8% of trials), the GF cue was a blue circle informing the patient that there was no risk to press the button because STOP cues never followed GF cues (Chikazoe et al., 2009 ). These trials were used to remove the proactive inhibition component, since subjects no longer had to prepare to inhibit their response during GF trials. Finally, during GC trials (GO-Continue; 15.8% of trials), a "continue" signal (a blue cross) appeared unpredictably after the GO cue (the delay was identical to the SSD of the preceding STOP trial). Subjects were then asked to respond to the GO cue as fast as they could and ignore the "continue" signal. GC trials provide a control condition to test the possibility that STN modulations previously observed during stopping could be related to attentional processes associated with the presentation of an unexpected visual stimulus. GO and GF cues were preceded by a variable fixation period (range: 500-1500 ms) and vanished after button press or after 1000 ms. "Continue" and STOP cue disappeared after 500 ms or after button press, in case of incorrect responses.
To maintain high attentional and motivational level, a feedback stimulus appeared 1000 ms after each trial to indicate success or failure to patients in the current trial. Successful trials were accompanied by a score increase of 1 point for GO, GF and GC trials and of 3 points for STOP trials. Unsuccessful trial feedbacks consisted of losing 1 point for GO, GF and GC trials and of 3 points for STOP trials, respectively. Note that the reward magnitude was higher during STOP trials because we wanted to match the sum of rewards that can be obtained across all trials between STOP and GO trials to avoid behavioral strategies that would only focus on GO/GF or GC trials to maximize overall reward magnitude. During feedback, both scores increase/decrease in the current trial and the total of points won previously were displayed. The ability to stop a response is related to the SSD value (the longer the SSD, the more difficult it is to stop). The SSD was varied from trial to trial to adjust task difficulty using a staircase procedure: if subjects succeeded in withholding the response in a STOP trial, the SSD increased by 50 ms; if they failed, SSD decreased by the same amount of time. The staircase procedure ensured that the subjects would succeed in withholding their response in around 50% of the stop trials. The initial SSD was based on results obtained from a training session that preceded the electrophysiological study (130 ± 21 SST trials performed by each subject during training). STOP trials were divided between Successful STOP and Unsuccessful STOP trials.
Patients performed 4 to 5 blocks of trials containing 190 trials each (100 GO, 30 STOP, 30 GF and 30 GC) . Trial order was pseudo-random and pooled in successive random sequences of 12 trials (using 3 STOP, 3 GF, 3 GC and 3 GO trials). An additional constraint was that a STOP trial could never be followed by another STOP trial, with one exception to this rule for each block of 190 trials to make sure that the subject was unaware of the design of the task.
Computational models have described the neural processes underlying the SST as a 'horse race' between GO and STOP processes evolving independently over time, whatever comes first determining the outcome of the action. To isolate reactive inhibition signals during the SST, we contrasted trials during which patients had to stop a prepared response (Successful STOP trials) to trials during which the STOP process was absent (GO trials). This comparison has been previously used to isolate reactive inhibition activities (Aron and Poldrack, 2006; Hanes et al., 1998; Ray et al., 2011) . Furthermore, according to predictions from the horse race model, the slowest GO responses (50% slower GO trials: Latency-Matched-GO trials) would have led to a successful inhibition if a stop signal had occurred during these trials (Ray et al., 2011; Verbruggen and Logan, 2008) . For this reason, we compared the STN activity between the 50% slower GO trials (Latency-Matched-GO) and Successful STOP trials to test the functional role of STN during reactive stopping. However, because Successful STOP and Latency-Matched-GO trials differed in terms of visual stimulation (Fig. 1B) , we also contrasted Successful STOP and Unsuccessful STOP trials to exclude the possibility that STN modulations during reactive stopping were driven by differences in visual stimulation. To summarize, comparison of activity between Successful STOP trials (trials with inhibition in response to a STOP cue) and Latency-Matched-GO trials, and between Successful STOP trials and Unsuccessful STOP trials, allowed us to determine the time course of reactive stopping activity. In contrast, comparison of STN activity between GO trials (trials with a preparation to stop component) and GF trials (trials without preparation to stop) centered on GO cue allowed us to determine the time course of proactive inhibition activity. Finally, comparison of activity between Successful STOP and GO Continue trials (trials with an unexpected stimulus) allowed us to examine attentional capture effects.
Data analysis
Response accuracy (% of correct trials) and reaction time (RT) were computed for every trial type. In addition, patient's inhibitory performance was estimated using the stop signal reaction time (SSRT), which was computed by subtracting the average SSD value to the average GO reaction time (Logan et al., 1984; Verbruggen and Logan, 2008) . To quantify the level of proactive inhibition, we computed the preparation cost by subtracting the mean reaction time of GF trials from the mean reaction time of GO trials (Chikazoe et al., 2009) .
Electrophysiological analyses were performed using custom Matlab (The MathWorks) routines used previously by our group (Bastin et al., , 2013a . The first step was to select one contact-pair within the motor STN of each hemisphere. For that purpose, under the assumption that βA is the intrinsic rhythm of Parkinsonian STN (Chen et al., 2006; Kuhn et al., 2004 Kuhn et al., , 2005 , we selected the contact-pair (among the 3) that showed a clear peak of spectral power in the βA during fixation (peak above mean + 1.96 std of the 5-200 Hz power spectrum) and that exhibited the largest decrease of βA during motor responses. STN contacts presenting more than 50% trials with artifacts (peak-topeak amplitude in the raw recordings above 50 μv) were rejected from the analysis. One patient presented a right STN electrode with no contact eligible for analysis: this STN side was not included in further analyses. In total, 23 motor STN contacts were selected from the 12 patients (12 on the left side, 11 on the right side). LFPs during trials were extracted around the stimuli of interest using 4 s epochs centered on each event. Artifacts were rejected if the peak-to-peak amplitude during a trial exceeded a threshold of 50 μv (using this criteria, 7 ± 2% of trials were rejected).
The main focus of our study was on the β frequency band. However, to study the possibility that other frequency bands could be modulated during the task, time frequency analysis of LFP power was also used to quantify STN modulations during reactive and proactive inhibition, based on a standard time-frequency wavelet decomposition. For each trial, the signal s (t) was convolved with a complex Morlet wavelet w(t, f0) defined as: w (t, f0) 1/4 A exp (− t 2 /2σ 2 t ) exp (2i πf 0 t), with σ f = 1/2 πσ t . We used a wavelet family with cycle number set to 7 A B Fig. 1 . Stop signal task and behavioral results. A. The stop-signal task designed for the present study used four trial types (GO, GF, GC and STOP). Before each trial, a fixation point was used. During most of the trials, patients were required to press a button as fast as they could (GO, GF and GC trials). During a minority of trials, a STOP cue followed the GO cue (ST trials), instructing patients to withhold their response. During GF trials, the GF cue was never followed by a STOP signal. During GC trials, an unexpected "continue" signal appeared after Go signal. At the end of each trial a feedback was presented (a score increase/decrease). B. Average across patients' reaction times (RT) measured during the SST for GO, GF, GC and Unsuccessful STOP. Stars represent significant differences (repeated measures ANOVA followed by a Newman-Keuls post hoc test; **p b 0.01; ***p b 0.001). Error bars represent ±1 SEM.
(i.e. f 0 /σ f = 7). The square norm of the convolution results in a timevarying representation of spectral power given by: P (t, f 0 ) = | w (t, f 0 ) ⊗ s(t)| 2 . The investigated frequency range was 1-150 Hz.
Then, single trial time-frequency maps were normalized for each frequency band by computing percentage of mean baseline power. The baseline used for each trial was the full visual fixation epoch that preceded each event (Fig. 1 , the duration of the baseline ranged from 500 to 1500 ms). Finally, time frequency maps for each trial type were averaged and submitted to statistical analyses at the group level (see below). Because we had strong prior hypotheses on the frequency of interest, we then focused all analyses on the time-course of β band activity . To estimate βA responses, LFP signals were bandpass filtered in 22 successive 1-Hz-wide frequency bands (e.g., 22 bands from [13-14 Hz] to [34-35 Hz] using a zero phase shift non causal finite impulse filter with 0.5 Hz roll-off). The envelope of each bandpass filtered signal was computed with a time resolution of 0.5 ms using Hilbert transform. The envelope amplitude was then divided by its mean across the entire recording session and scaled by a factor 100 to express changes of βA in percentages of the mean. Finally, the normalized envelope signals computed for each consecutive frequency band (e.g., 22 bands of 1 Hz intervals between 13 and 35 Hz) were averaged together to provide one single time-course (the βA) across the entire session. This time series of βA was epoched for each trial (4 s time window centered on the stimulus of interest).
For each STN contact, a significant modulation of βA evoked by GO, GF, GC and Successful STOP trials was identified if the βA response was significantly above the level of βA observed during a 500 ms prestimulus baseline (5% significance threshold, mean baseline βA ± 1.96 std). We also estimated the onset latency and peak latency of significant βA modulations. To compute the onset latency of βA response for each trial type of interest, we used change point analyses (Gallistel et al., 2004) . Change point is a recursive algorithm using cumulative sum charts to detect remarkable change in the time series. First, the algorithm computes for each point the deviations of every earlier point. The point for which the deviation is maximal relative to each point analyzed is defined as a putative change point. Second, it computes the strength of evidence that the deviation seen at the putative change point exceeds the decision criterion (p b 0.01, Kolmogorov-Smirnoff test). To avoid violation of the assumption of independent errors, βA was downsampled to 200 Hz and data points were pooled in groups of 5 for onset calculation. βA response onset was thus calculated with a temporal precision of ±25 ms.
When comparing Successful STOP trials and Unsuccessful STOP trials or GC trials, we quantified modulations of STN βA stimulus-locked to the GO cue and modulations of STN βA stimulus-locked to the second stimulus (STOP or CONTINUE cue).
The latency of the peak of βA response was defined as the time point at which the βA modulation reached its maximum. The onset latency at which the βA response during Successful STOP trials started to significantly differ from activity in Latency Matched Go or Unsuccessful STOP trials was determined using two steps: we first computed the Successful STOP − Latency Matched Go and Successful STOP − Unsuccessful STOP difference (in terms of βA in the STN). Secondly, we estimated the time point at which this βA difference from GO cue significantly differed from zero, using a threshold that was set using the average βA measured during a 500 ms pre-stimulus time period (± 1.96 S.D.).
We added an additional constraint that the effect duration had to exceed the significance threshold for at least 100 ms in order to avoid false positive estimates. Finally, βA measured in a time interval separating the GO cue onset and the peak of βA response was computed in all subjects, separately during GO and GF trials. The difference in βA between GF and GO trial types was termed "Preparation to Inhibit Effect". In addition, βA during a 600 ms time interval preceding response onset was also used to compare GO and GF trials. This second analysis was used to exclude the possibility that RT differences in these conditions could bias the preceding electrophysiological analysis.
Statistical analyses
Statistical analyses on time-frequency maps (multiple unpaired t-tests) were carried out using built-in functions of the Statistical Parametric Mapping (SPM) software for EEG (Kiebel et al., 2005) . To avoid false positive detection due to sharp transients in time and frequency axes, clusters in the time-frequency domain were considered as significant if task-related modulations exceeded the statistical threshold at least during 50 ms in a frequency range larger than 2 Hz.
Statistical analyses for behavioral measures and βA responses were carried out using Graph-Pad (Graphpad Software). Repeated measures ANOVA were followed with a post-hoc Tukey test where within conditions comparison was necessary. Non parametric tests (Friedman tests followed by post-hoc Dunn test) were used, when necessary (if data was not normally distributed or if variances were not homogeneous). When only two types of trials were compared, we used paired t-tests or Wilcoxon matched paired rank tests. The significance of correlations was assessed using Pearson's correlation test or Spearman's correlation test when necessary (if data was not normally distributed). The statistical level of risk chosen in this study was 5%.
Results
Behavioral results
Patients performed the task accurately (mean success rate was 92 ± 2% in GO trials and 50 ± 3% in STOP trials.). As expected, the accuracy during STOP trials was significantly lower than during GO trials (Friedman's test performed on success rates with factor trial Type [GO, GF, GC, Unsuccessful STOP]; F(11,3) = 30.28, p b 0.0001; Dunn's post-hoc test: p = 0.0124). The accuracy observed during GC trials (85 ± 5%) and GF trials (96 ± 1%) was not significantly different from the accuracy observed during GO trials (Dunn's post-hoc test GO versus GC, p = 0.99 and GO versus GF, p = 0.1315). Patient's RTs were significantly faster during GF trials than during both GC and GO trials ( Fig. 1B; F(11,3) = 21.53, p b 0.0001; Tukey post-hoc tests: GF versus GO: p = 0.0106; GF versus GC: p = 0.0329). The cost of the "preparation to stop" component, measuring the level of proactive inhibition was 70 ± 10 ms. No significant difference in RT was observed between GC and GO trials thus demonstrating that in these trials no inhibition was triggered by the "continue" signal (Tukey post-hoc tests: p = 0.4875). The SSRT was on average 402 ± 22 ms and the mean SSD was 227 ± 28 ms. Our behavioral results are compatible with the assumption of go and stop processes independence (Logan et al., 1984) , because reaction times measured during GO trials did not correlate with patient's SSRT (r(11) = 0.47, p = 0.123) and reaction times during Unsuccessful STOP trials were significantly shorter than reaction times during GO trials (ANOVA: F(11,3) = 21.53, p b 0.0001; Tukey post-hoc test p = 0.0001). Overall, patients accurately performed the modified SST and behavioral performances were similar to those observed in previous studies with PD patients (Gauggel et al., 2004; Obeso et al., 2011; Ray et al., 2009 ).
Task-related STN modulations during inhibition
We first quantified task-related STN activities using time-frequency analyses (Fig. 2) . To unmask the processes underlying reactive inhibition, successful STOP trials were compared to Latency Matched GO (50% slowest go trials, see Methods). We found that a decrease of βA occurred after the GO signal during both conditions. However, the magnitude of the decrease was significantly lower during Successful STOP trials than during GO trials at latencies ranging from 560 to 1085 ms (paired t-test, p b 0.05 uncorrected for multiple comparisons).
This effect no longer reached significance after the False Discovery Rate correction for multiple comparisons (Genovese et al., 2002) . To examine proactive inhibition, we compared GO trials and GO fast trials. This contrast did not reach significance. No difference of response was observed in other frequency bands. We thus further examined the time course of STN βA with more extended analyses presented below.
βA is rapidly modulated during reactive inhibition
We examined if the time course of STN βA supported our hypothesis of STN implication during reactive inhibition. Hence, if the STN behaves like a brake to quickly suppress inappropriate responses, its activity should differentiate between Successful STOP and Latency-Matched-GO trials before the SSRT. We observed that βA significantly decreased during both Successful STOP and Latency Matched Go trials in 21 out of 23 recorded STN sides (Fig. 3A) . Next, we compared the temporal profile of βA response evoked by Successful STOP and Latency-Matched-GO trials in these contact-pairs (Fig. 3A) . We first quantified the onset latency and the peak latencies of the βA decrease for each selected STN contactpair. The peak latency occurred significantly earlier during Successful STOP than during Latency-Matched-GO trials ( Fig. 3E ; respectively 474 ± 37 ms vs. 727 ± 37 ms relative to the GO cue; t(20) = 7.104, p = 0.0001). Moreover, when calculated relative to the STOP cue, the peak latency of STN activity significantly preceded the SSRT during Successful STOP trials ( to significantly differ between Successful STOP and Latency-Matched-GO trials (Fig. 3C , see Methods, n = 21 STN showing a significant difference). The relative βA increase during Successful STOP trials started to become significant at 290 ± 42 ms after the STOP cue (t(20) = 6.989, p b 0.0001), and occurred 110 ± 39 ms before the SSRT (t(20) = 2.786, p = 0.0114; Fig. 3G ). These results suggest that the interruption of βA decrease could reflect a fast "stop signal" in the STN during reactive stopping, interrupting the motor related βA decrease. One alternative interpretation to these results is that the occurrence of STOP cue during Successful STOP could account by itself for the early interruption of βA decrease, e.g. reflecting an oddball effect. We ruled out this possibility by comparing βA during Successful STOP and Unsuccessful STOP trials. Analyses of STN βA stimulus-locked to the GO cue revealed qualitatively similar results: the peak latency of βA decrease occurred earlier during Successful STOP (W(20) = − 160, p = 0.0057) and the peak amplitude of βA decrease was lower during Successful STOP (t(20) = 5.842, p b 0.0001).
Analyses locked to the STOP cue confirmed that the decrease of βA was of lower amplitude and was interrupted at a significantly earlier latency during successful than during unsuccessful stopping (Fig. 3B) . The peak latency of βA occurred significantly earlier during Successful STOP than during Unsuccessful STOP trials (peak latency was respectively 233 ± 41 ms vs. 316 ± 42 ms relative to the STOP cue; Wilcoxon test: W(20) = − 149; p = 0.0101). The peak amplitude of βA relative to the STOP cue was also significantly reduced during successful STOP trials as compared to unsuccessful STOP trials (respectively − 7 ± 0.8% vs. − 12 ± 1.3%; t(20) = 5.35, p b 0.0001). Note that the onset latency of βA decrease relative to the STOP cue was not significantly different (− 447 ± 81 ms during Successful STOP and − 557 ± 68 ms during Unsuccessful STOP, t(20) = 1.281, p = 0.2148). We computed the onset latency at which the STN activity started to significantly differ between Successful STOP and Unsuccessful Stop (Fig. 3D) . The onset of the relative βA increase measured through the difference between Successful STOP and Unsuccessful STOP trials relative to the STOP cue significantly preceded the SSRT (t(21) = 9.515, p b 0.0001).
Secondly, we compared the pattern of βA activity during STOP and GO "continue" (GC) trials, because GC trials were designed to test the attentional capture hypothesis (Sharp et al., 2010) . We found that βA decrease during GC trials started at a latency that was not significantly different from Successful STOP trials (t(20) = 1.28, p = 0.54). The peak amplitude of the βA decrease during Successful STOP was significantly lower than during GC ( Fig. 4B ; respectively − 7 ± 0.8% vs. −9.6 ± 1%; t(20) = 4.79, p b 0.001) and βA decrease was interrupted at a significantly earlier latency during Successful Stop trials (Wilcoxon test, W(20) = −131; p = 0.0239).
βA modulation during the preparation to stop predicts inhibitory performances
To test the possibility that the STN could also mediate proactive inhibition signals (Aron, 2011; Chikazoe et al., 2009) , we compared trials during which patients prepared themselves to potentially suppress inappropriate responses (GO trials) to trials during which they were sure that no STOP signal would occur (GF trials). If STN plays an active role during proactive inhibitory control, we should observe a tonic modulation of βA when proactive inhibitory control is needed. We indeed found a significant βA decrease during both GF and GO trials for all 23 STN contacts (Fig. 4A) . Moreover, the amplitude of the peak of the βA decrease was significantly higher during GF trials than during GO trials (−11.1 ± 1.4% vs. −9.7 ± 1.2%, respectively; t(22) = 3.102, p = 0.0052; Fig. 4E ), whereas neither the latency at which the βA peak occurred (t(22) = 0.5307, p = 0.60) nor the onset latency of βA decrease (W(22) = 1.489, p = 0.1358) was statistically different between GF and GO trials. This demonstrates that βA decrease when subjects prepare to inhibit their response is less pronounced compared to when this "hold your horse" signal is absent. Next, we calculated the average βA from GO/GF cues to the peak of the βA decrease, i.e. during a time interval lasting on average 573 ± 29 ms. This analysis confirmed that the magnitude of βA decrease was significantly greater during GF than during GO trials ( Fig. 4C ; t(22) = 2.39, p = 0.0259). In addition, the difference of STN activity during GF and GO trials during this time interval (the "preparation to stop effect", Chikazoe et al., 2009 ) was negatively correlated with the SSRT (n = 22; r = −0.5251, p = 0.0101). This demonstrates that STN modulations during proactive inhibitory control predicted inhibitory performance of subjects: the higher the level of βA in the STN during the preparation to stop, the lower the SSRT (Fig. 4D) . To exclude the possibility that differences of reaction times between GF and GO could explain this difference, we ran a control analysis using button presses as triggers during GO and GF trials (see Methods) . Differences in βA between GO and GF trials measured in the 600 ms time interval preceding button presses was qualitatively similar. We found that the magnitude of the decrease of βA was larger in GF compared to GO trials (− 5.5 vs − 4.9% respectively, W(22) = 161; p = 0.015), and the magnitude of this difference predicted subjects' inhibitory performance (n = 22; r = − 0.4279, p = 0.0417). To examine the reliability across patients of the relationship found between the preparation to stop effect and SSRT, we averaged across each patients' hemispheres the data (n = 12 patients). This reanalysis revealed that the correlation was even stronger using this procedure (n = 12; r = − 0.664; p = 0.018). However, the correlation no longer reached significance when the time interval preceding button presses was used, after pooling left and right STN data (n = 12; r = − 0.44; p = 0.148), because the statistical power became too low.
Discussion
The main finding of this study is that the temporal dynamics of STN activity dissociates two forms of executive processes, namely reactive and proactive inhibitory signals. We showed that the decrease of βA in the STN, observed during GO trials, is prematurely interrupted during reactive stopping (Successful STOP trials) at a latency that precedes the SSRT by~100-150 ms. This result is in agreement with the hypothesis that the STN plays a central role in the stopping network to quickly suppress inappropriate motor responses (Aron and Poldrack, 2006; Frank et al., 2007; Pouget et al., 2011) . Furthermore, we showed that the STN is modulated by proactive inhibitory control (i.e. during the preparation to inhibit a response), and we demonstrate that the amplitude of this modulation predicts subject's reactive stopping performance and last~550 ms (i.e. the time interval between GO cue onset and the onset of βA peak). Those findings suggest the existence of two distinct temporal dynamics mediating distinct forms of executive control functions. In that case, the quick interruption of βA decrease following a STOP cue may mediate reactive inhibitory signals whereas the relative increase of βA observed when subjects prepared themselves to eventually inhibit their responses may reflect a proactive inhibitory readiness signal used to optimize performance of basal ganglia outflow (Aron, 2011; Ballanger et al., 2009; Chikazoe et al., 2009) .
Before developing further the theoretical impact of our findings, let us consider some of the limitations inherent to studies with PD patients. Because PD has been associated with increased βA in the sensorimotor STN (Brown and Williams, 2005; Trottenberg et al., 2007; Zaidel et al., 2010) , whether the task-related modulations of STN activity we observed are physiological or rather represent enhanced beta activity primarily related to parkinsonism remains controversial. Two arguments suggest that it seems likely that this study reflect modulations of the STN close to physiological activity: first, we recorded PD patients in ON-drug condition when they had relatively little Parkinsonian signs (UPDRS ON Levodopa as low as 12.8 ± 2/108) and it is well-known that dopaminergic medication tends to normalize STN neuronal activity (Levy et al., 2002) . Second, we used an experimental design where each patient was its own control, so that task-related activities are unlikely to solely reflect the pathological state of PD patients.
Reactive inhibition is supported by a fast interruption of βA decrease in the STN
We found a quick interruption of βA decrease in the STN during reactive inhibition. We hypothesize that it might reflect a fast brake signal used in the cortico-basal ganglia circuitry to stop inappropriate responses (Aron and Poldrack, 2006; Frank et al., 2007; Swann et al., 2011) . Previous neurophysiological work in monkeys showed that signals enabling the switching from a reactive to a more controlled behavior are produced by some STN neurons at a latency of about 70 ms before the switch reaction time (Isoda and Hikosaka, 2008) . In humans, the neuronal latency of the reactive stopping signal within the STN remains unclear, despite several reports showing significant βA modulations during reactive inhibition in the STN (Alegre et al., 2012; Kuhn et al., 2004; Ray et al., 2011) . Although variations of STN activity in the beta band underlying the response inhibition mechanisms were previously reported (Alegre et al., 2012; Isoda and Hikosaka, 2008; Ray et al., 2011) , to our knowledge, this study is the first that precisely measures the time course of reactive inhibitory signals in the human STN and demonstrate that the timing of STN activity was early enough to support reactive inhibitory function.
This result also extends to a subcortical structurethe previous observation that βA increases in the inferior frontal gyrus (IFG) during stopping, at a similar latency before SSRT (Swann et al., 2009 ). Anterograde tracers into STN pre-motor, limbic and associative areas have demonstrated the existence of a hyperdirect projection from these areas (Haynes and Haber, 2013) , in addition to the hyperdirect motor loop (Monakow et al., 1978; Nambu et al., 1996) . This suggests a major role of the hyperdirect premotor cortex-subthalamic entry to the basal ganglia relaying control on basal ganglia outflow in cognitive, limbic and motor activities. We speculate that βA selectively involved during reactive stopping could reflect a rapid communication between the prefrontal cortex and the STN via the hyperdirect loop (Hauser et al., 2007) . Previous studies indicated that stopping inappropriate responses strongly involve the STN and might underlie its critical role in controlling impulsivity and in suppressing unwanted ballistic movements (Baunez et al., 1995; Crossman et al., 1984; Frank et al., 2007; Jahanshahi et al., 2000) . In addition, bilateral STN high frequency stimulation improves inhibitory performance by shortening the SSRT (Swann et al., 2011; van den Wildenberg et al., 2006) , while increasing βA in the right frontal cortex (Swann et al., 2011) . These results support the hypothesis that cortical-STN communication in the beta band could implement reactive inhibitory processes (Swann et al., 2011) . Our study provides a missing link between these previous findings by demonstrating that specific stopping responses in the STN are exhibited at short latencies, exactly as one would expect if the STN acts as a brake in the motor network by mediating a fast stopping signal through a relative increase of beta band oscillation power.
Because the SST requires subjects to attend to the stimulus (in addition to inhibiting the prepared action), and because animal studies have demonstrated attentional capture deficits after STN lesions (Baunez et al., 1995; Chudasama et al., 2003; Frank et al., 2007; Jahanshahi et al., 2000) , STN responses during the SST could also reflect a form of attentional capture by rare, yet behaviorally relevant, stimuli (oddball effect). To rule out this alternative interpretation of the early relative increase of βA observed during reactive stopping, we used an experimental condition that was specifically developed to address this possible confound (Sharp et al., 2010) .
Our results show that attentional capture could not explain the reactive stopping effect as our comparison between Successful STOP and GO Continue trials was highly significant: this clearly ruled out the possibility that the early interruption of βA decrease observed during stopping was induced by a simple oddball effect. Moreover, this early interruption of βA was highly selective, since it was also absent during Unsuccessful STOP trials. This findings contradict results from a previous study (Ray et al., 2011) and might merely reflect a difference of statistical power (in this study, more patients were included and each patient completed a higher number of trials).
Proactive inhibition is supported by a sustained increase of βA This study demonstrates that βA was higher in the STN when patients had to prepare to inhibit a response, during proactive inhibition, and that proactive signals may facilitate reactive stopping when it becomes necessary. This finding supports the hypothesis that when subjects face a situation where response caution is needed, the STN triggers a "hold your horse" signal to get more time in order to select the appropriate action (Frank et al., 2007) . This interpretation is in line with previous neuroimaging, behavioral and clinical validations of this model: STN activation is higher during slower and more accurate decisions (van Maanen et al., 2011) , and disrupting STN activity through high frequency stimulation promotes impulsive behavior and decreases proactive inhibitory control (Baunez et al., 1995; Frank et al., 2007; Jahanshahi et al., 2000) .
Our findings further support this hypothesized role of the STN in proactive inhibition, with the additional information that the strength of this proactive signal improved reactive stopping performance. This is in line with previous fMRI studies linking pre-activation of the stopping network and improvement of reactive inhibition (Chikazoe et al., 2009; Jahfari et al., 2010) . We therefore propose that the neuronal mechanism observed during the preparation to inhibit could correspond to a pre-activation of the STN when subjects anticipate the possibility that they could have to inhibit their response in the near future.
Conclusion
To sum up, our results demonstrate the existence of at least two different temporal dynamics in the STN, implementing two forms of executive control functions: whereas reactive stopping signals are supported by early STN responses, proactive stopping signals are mediated by a more sustained STN activity that also predicts subjects' inhibitory performances during the SST.
